← Leaderboards
Qiang Yang
Glycot Therapeutics, Llc
$3,167,103
Attributed
$3,167,103
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $864.1K · FY2017–23$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,167,103 · 6
By mechanism
R44$2,034,195 · 2
R43$1,132,908 · 4
Top collaborators
No co-investigators on record.
Most similar at Glycot Therapeutics, Llc
Same institution · by research overlap
- Guanghui Zong$2,449,755
Others in their field
Other Emerging Leaders on “Polysaccharides”
- Aaron Gregory Schmidt · Boston Children'S Hospital$11,393,862
- Mohamed Abdel Mohsen · Wistar Institute$10,270,954
- Christian Harding · Vaxnewmo, Llc$10,084,816
- Frederick Porter · Duke University$7,872,076
- Jeongmin Song · Cornell University$7,814,606
- Raiees Ahmad Andrabi · Scripps Research Institute, The$7,749,909
Research focus
PolysaccharidesGlycosylationDrug KineticsEndoglycosidasesAntibodiesPhase 1 StudyMarylandUniversitiesSiteHeterogeneityEngineeringSuccessPreparationEnzymesProteinsIn VivoMutantTechnologyScale UpProtocols DocumentationReactionIndustrializationProductionMouse Model
Grant awards (9)
Development of a facile, robust, scalable, and versatile chemoenzymatic glycan-remodeling approach for site-specific antibody conjugation$89,704
R43 · FY2023 · GM · contact PI
Development of a facile, robust, scalable, and versatile chemoenzymatic glycan-remodeling approach for site-specific antibody conjugation$231,535
R43 · FY2022 · GM · contact PI
Development of streamlined chemoenzymatic glycan remodeling systems for antibodies and other important glycoproteins$774,934
R44 · FY2021 · GM · contact PI
Chemoenzymatic Glycan Remodeling of IVIG for Improved Anti-inflammatory Activity$545,196
R44 · FY2020 · GM · contact PI
Development of streamlined chemoenzymatic glycan remodeling systems for antibodies and other important glycoproteins$150,000
R43 · FY2020 · GM · contact PI
Chemoenzymatic Glycan Remodeling of IVIG for Improved Anti-inflammatory Activity$714,065
R44 · FY2019 · GM · contact PI
Development of streamlined chemoenzymatic glycan remodeling systems for antibodies and other important glycoproteins$150,000
R43 · FY2019 · GM · contact PI
Chemoenzymatic synthesis of stable isotope-labeled glycopeptides as internal standards for glycosylation quantitation$292,823
R43 · FY2018 · GM · contact PI
Chemoenzymatic glycan remodeling of IVIG for improved anti-inflammatory activity$218,846
R43 · FY2017 · GM · contact PI